Federal Register / Vol. 75, No. 227 / Friday, November 26, 2010 / Rules and Regulations 72679 

COORDINATION OF RETIREMENT AND EFFECTIVE DATES TABLE—Continued 

Existing approved 

standard 

Requirement to be 

retired or replaced 

Proposed 

standard 

New requirement 

to be implemented Date for concurrent retirement and implementation 

R2.1 

PER–004–1 .................... R3 

R4 

PER–002–0 .................... R4 PER–005–1 R3 1st day of 1st calendar quarter after regulatory approval. 

PER–004–1 .................... R2 

PER–004–1 .................... R1 PER–004–2 R1 1st day of 1st calendar quarter after regulatory approval. 

R5 R2 

N/A .................................. N/A PER–005–1 R3.1 1st day of 1st calendar quarter 36 months after 

regulatory approval. 

[FR Doc. 2010–29717 Filed 11–24–10; 8:45 am] 

BILLING CODE 6717–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

21 CFR Part 510 

[Docket No. FDA–2010–N–0002] 

New Animal Drugs; Change of 

Sponsor’s Name and Address 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Final rule. 

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations to reflect a 

change of sponsor’s name from Belcher 

Pharmaceuticals, Inc., to Belcher 

Pharmaceuticals, LLC. The sponsor’s 

mailing address will also be changed. 

DATES: This rule is effective November 

26, 2010. 

FOR FURTHER INFORMATION CONTACT: 

Steven D. Vaughn, Center for Veterinary 

Medicine (HFV–100), Food and Drug 

Administration, 7520 Standish Pl., 

Rockville, MD 20855; 240–276–8300, email: steven.vaughn@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Belcher 

Pharmaceuticals, Inc., 12393 Belcher 

Rd., suite 420, Largo, FL 33773 has 

informed FDA that it has changed its 

name and address to Belcher 

Pharmaceuticals, LLC, 6911 Bryan Dairy 

Rd., Largo, FL 33777. Accordingly, the 

Agency is amending the regulations in 

21 CFR 510.600 to reflect this change. 

This rule does not meet the definition 

of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because 

it is a rule of ‘‘particular applicability.’’ 

Therefore, it is not subject to the 

congressional review requirements in 5 

U.S.C. 801–808. 

List of Subjects in 21 CFR Part 510 

Administrative practice and 

procedure, Animal drugs, Labeling, 

Reporting and recordkeeping 

requirements. 

■ Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under 

authority delegated to the Commissioner 

of Food and Drugs and redelegated to 

the Center for Veterinary Medicine, 21 

CFR part 510 is amended as follows: 

PART 510—NEW ANIMAL DRUGS 

■ 1. The authority citation for 21 CFR 

part 510 continues to read as follows: 

Authority: 21 U.S.C. 321, 331, 351, 352, 

353, 360b, 371, 379e. 

■ 2. In § 510.600, in the table in 

paragraph (c)(1), revise the entry for 

‘‘Belcher Pharmaceuticals, Inc.’’; and in 

the table in paragraph (c)(2), revise the 

entry for ‘‘062250’’ to read as follows: 

§ 510.600 Names, addresses, and drug 

labeler codes of sponsors of approved 

applications. 

* * * * * 

(c) * * * 

(1) * * * 

Firm name and address Drug labeler code 

* * * * * 

Belcher Pharmaceuticals, LLC, 

6911 Bryan Dairy Rd., Largo, 

FL 33777.

062250 

* * * * * 

(2) * * * 

Drug labeler code Firm name and address 

* * * * * 

062250 .... Belcher Pharmaceuticals, LLC, 

6911 Bryan Dairy Rd., Largo, 

FL 33777. 

* * * * * 

Dated: November 19, 2010. 

Elizabeth Rettie, 

Deputy Director, Office of New Animal Drug 

Evaluation, Center for Veterinary Medicine. 

[FR Doc. 2010–29693 Filed 11–24–10; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF THE INTERIOR 

Bureau of Ocean Energy Management, 

Regulation and Enforcement 

30 CFR Part 285 

[Docket ID: BOEM–2010–0045] 

RIN 1010–AD71 

Renewable Energy Alternate Uses of 

Existing Facilities on the Outer 

Continental Shelf—Acquire a Lease 

Noncompetitively 

AGENCY: Bureau of Ocean Energy 

Management, Regulation and 

Enforcement (BOEMRE), Interior. 

ACTION: Direct Final rule. 

SUMMARY: BOEMRE is revising 

regulations that pertain to 

noncompetitive acquisition of an Outer 

Continental Shelf (OCS) renewable 

energy lease. We are taking this action 

because the current regulations covering 

noncompetitive leasing of an OCS 

renewable energy lease and an 

unsolicited request for an OCS 

renewable energy lease are inconsistent. 

This rulemaking will make the two 

processes consistent with each other by 

eliminating an extra step in the 

noncompetitive leasing process. 

DATES: Effective Date: This rule becomes 

effective on January 25, 2011 unless 

BOEMRE publishes a notice 

withdrawing this rule before that date. 

Comment Due Date: Submit 

comments on the direct final rule by 

December 27, 2010. 

FOR FURTHER INFORMATION CONTACT: 

Timothy Redding at (703) 787–1219. 


srobinson on DSKHWCL6B1PROD with RULES